Boundless Bio owners buy 1,700 shares at $2.40
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Boundless Bio, Inc. (BOLD) ten-percent owners Kevin Tang and Tang Capital Management LLC reported indirect purchases of 1,700 common shares on November 6, 2026, at a weighted-average price of $2.40 per share; prices ranged from $2.39 to $2.40. They also reported an indirect purchase of 249 shares on November 10, 2026, at $2.40 per share. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F3, F2 | 249 | $2.40 | $597.60 |
| Purchase | Common Stock F1, F2 | 1,700 | $2.40 | $4K |
Footnotes (3)
- F1. The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $2.39 to $2.40. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the range set forth in Footnotes 1 and 3.
- F2. Tang Capital Partners, LP ("TCP") beneficially owns 691,177 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 974,622 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 691,170 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 678,598 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV.
- F3. These shares were all purchased at $2.40.
Key Figures
Key Terms
weighted-average prices financial
beneficially owns regulatory
pecuniary interest regulatory
general partner regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.